US Chamber Backs Amgen In FTC's $27.8B Merger Challenge
By Renee Hickman · August 29, 2023, 9:31 PM EDT
The U.S. Chamber of Commerce is backing biotechnology company Amgen in its bid to complete a $27.8 billion merger with Horizon Therapeutics, saying in an amicus brief Tuesday that if the...
To view the full article, register now.